Home > > Middle East & Africa And Global Point of Care Molecular Diagnostics Market- Size, Share, Growth Rate, and Forecast
The Middle East & Africa Point of Care Molecular Diagnostics market was valued at $380.2 Million in 2023, and is projected to reach $566.4 Million by 2030 growing at a CAGR of 5.91% from 2024 to 2030. Infectious disease segment is expected to be the highest contributor to this market, with $192.3 Million in 2023, and is anticipated to reach $295.0 by 2030, registering a CAGR of 6.35%. Infectious disease and Oncology segments collectively expected to account for about 78.1% share of the Middle East & Africa Point of Care Molecular Diagnostics market in 2023, with the former constituting around 50.6% share. Infectious disease and Oncology segments are expected to witness significant growth rates at a CAGR of 6.35% and 5.84% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 78.1% in the overall Middle East & Africa Point of Care Molecular Diagnostics market in 2023, and is anticipated to reach 79.5% by 2030. Application Infectious disease Oncology Hematology Other Applications End user Hospitals Clinics Other End users Technology PCR In situ hybridization Sequencing Isothermal amplification Other Technology BY REGION North America U.s. Canada Mexico Europe Germany France UK Italy Spain Rest of Europe Asia China India Japan South Korea Australia Rest of Asia Middle East & Africa Brazil South Africa GCC Rest of MENA